Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

57%

4 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 3

3(50.0%)

Phase 2

1(16.7%)

Phase 4

1(16.7%)

N/A

1(16.7%)

6Total

Phase 3(3)

Phase 2(1)

Phase 4(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03297034Recruiting

Swiss Childhood Cancer Survivor Study

Role: collaborator

NCT03017326Phase 3Active Not Recruiting

Paediatric Hepatic International Tumour Trial

Role: collaborator

NCT01949129Phase 2Recruiting

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Role: collaborator

NCT00876031Phase 3Completed

Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma

Role: collaborator

NCT00107081Phase 3Terminated

Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting

Role: lead

NCT02670564Phase 4Recruiting

ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)

Role: lead

NCT02324231Not ApplicableCompleted

SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia

Role: lead

All 7 trials loaded